OVID earnings: next report 2026-08-12, real EPS beat/miss history, analyst consensus Buy, P/E -6.88. Updated 2026-07-23.
Ovid Therapeutics (OVID) Research Hub
Ovid Therapeutics (OVID) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 2.69 USD (-0.37%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -6.88, market cap 0.31B. This hub links to the full technical, earnings and options research available for OVID.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.69 USD (-0.37%) |
| 52-week range | 2.2 USD – 2.95 USD |
| Trend regime | Range |
| 14-day RSI | 53.2 (Neutral) |
| Trailing P/E | -6.88 |
| Market cap | 0.31B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for OVID
Covered Call on OVID: how it works, illustrative setup around the real 2.69 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on OVID: how it works, illustrative setup around the real 2.69 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on OVID: how it works, illustrative setup around the real 2.69 USD price, max profit/loss, breakeven and when to use it. Educational.
OVID technical analysis: range, last 2.69 USD, RSI 53.2, 52w range 2.2 USD–2.95 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is OVID in?
Ovid Therapeutics (OVID) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is OVID in an uptrend or downtrend?
As of 2026-09-11, OVID is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is OVID's trailing P/E ratio?
OVID's trailing P/E is -6.88, with a market cap of 0.31B. See the earnings research page for full valuation detail.
When does OVID next report earnings?
OVID is next scheduled to report earnings on 2026-08-12, with a consensus EPS estimate of -0.1 USD.